Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...
The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...
Overall, MajesTEC-3 signals a meaningful step forward for combination bispecific therapies in multiple myeloma, while ...
More than 370,000 insured patients in the US underwent kidney stone surgery in 2019, highlighting the importance of the 2026 AUA guidelines.
The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...
Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth.
GPblog UK on MSN
Tech Analysis | How the MCL39 'risky' front suspension unlocked even more performance
During the three days of testing in Bahrain, McLaren clearly seemed to have the quickest car with a little gap in front of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback